Home Authors Posts by Julianna LeMieux, PhD

Julianna LeMieux, PhD

122 POSTS 0 COMMENTS
Julianna LeMieux is a science writer at GEN/IPM where she covers synthetic biology genomics infectious disease, genome editing, and more. Previously, she spent years training at the bench while studying pathogenic bacteria during her PhD and postdoc.
close up asian chinese nurse drawing blood from female chinese patient arm's vein in the clinic
Liquid Biopsies

GRAIL Validates its Methylation-Based Cancer Detection Liquid Biopsy

Micrograph of multiple myeloma neoplasm from bone marrow biopsy
Multiple Myeloma

Fatty Acid Binding Protein Aids Multiple Myeloma Progression

T-cells attacking cancer cell illustration of microscopic photos
News & Features

Cancer Vaccine Prevents Recurrence in Mice

coronavirus
Coronavirus

Data Rules: Looking Inside the Pandemic Prevention Institute with Kaitlyn Johnson

outline image of a woman with breast cancer. The treatment of which can be improved using the antioxidant N-acetylcysteine
Breast Cancer

Triple-Negative Breast Cancer’s Metastatic Drivers Revealed

Cancer cells on dna stand background. 3d illustration
News & Features

Cancer Risk May Be Influenced by Rare Germline Variants

CRISPR
CRISPR

Novel Genome Editing System Efficient and Safe

close up asian chinese nurse drawing blood from female chinese patient arm's vein in the clinic
Liquid Biopsies

Liquid Biopsy Nanopore Technology Detects Cancer Biomarkers

Cancer cell attacked by Lymphocytes
Molecular Dx

Researchers Uncover How Tumors Make Immune Cells Go Rogue

DNA code cartoon
Molecular Dx

Ultima Genomics Targets the ‘$100 Genome’ With Almost $600M Funding

123...13Page 1 of 13

Trending

“Village” Cell Culture Offers Disease Insights

“Village” Cell Culture Offers Disease Insights

Diabetes Drug Metformin Lowers Risk of Developing Long COVID

Diabetes Drug Metformin Lowers Risk of Developing Long COVID

Penn Medicine Nabs $6M NIH Grant to Study Cardiac Cell Development

Penn Medicine Nabs $6M NIH Grant to Study Cardiac Cell Development

Out of the Gate: Kate Tx Nets $51M And Astellas Gene Therapy Deal

Out of the Gate: Kate Tx Nets $51M And Astellas Gene Therapy Deal

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine